These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 9494124)
1. Position- and base pair-specific comparison of p53 mutation spectra in human tumors: elucidation of relationships between organs for cancer etiology. Lutz WK; Fekete T; Vamvakas S Environ Health Perspect; 1998 Apr; 106(4):207-11. PubMed ID: 9494124 [TBL] [Abstract][Full Text] [Related]
2. P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers. Lasky T; Silbergeld E Environ Health Perspect; 1996 Dec; 104(12):1324-31. PubMed ID: 9118874 [TBL] [Abstract][Full Text] [Related]
3. p53 mutations in breast cancer. Coles C; Condie A; Chetty U; Steel CM; Evans HJ; Prosser J Cancer Res; 1992 Oct; 52(19):5291-8. PubMed ID: 1394133 [TBL] [Abstract][Full Text] [Related]
4. A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database. Hernandez-Boussard TM; Hainaut P Environ Health Perspect; 1998 Jul; 106(7):385-91. PubMed ID: 9637795 [TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures--Report 2015: The burden of rare cancers in Italy. ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748 [TBL] [Abstract][Full Text] [Related]
6. p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment. Harris CC Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):435-9. PubMed ID: 8781359 [TBL] [Abstract][Full Text] [Related]
7. Organ specificity of the bladder carcinogen 4-aminobiphenyl in inducing DNA damage and mutation in mice. Yoon JI; Kim SI; Tommasi S; Besaratinia A Cancer Prev Res (Phila); 2012 Feb; 5(2):299-308. PubMed ID: 22086680 [TBL] [Abstract][Full Text] [Related]
8. Comparison of induced and cancer-associated mutational spectra using multivariate data analysis. Lewis PD; Manshian B; Routledge MN; Scott GB; Burns PA Carcinogenesis; 2008 Apr; 29(4):772-8. PubMed ID: 18296683 [TBL] [Abstract][Full Text] [Related]
9. IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer. Hernandez-Boussard T; Rodriguez-Tome P; Montesano R; Hainaut P Hum Mutat; 1999; 14(1):1-8. PubMed ID: 10447253 [TBL] [Abstract][Full Text] [Related]
10. Tumors associated with p53 germline mutations: a synopsis of 91 families. Kleihues P; Schäuble B; zur Hausen A; Estève J; Ohgaki H Am J Pathol; 1997 Jan; 150(1):1-13. PubMed ID: 9006316 [TBL] [Abstract][Full Text] [Related]
11. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413 [TBL] [Abstract][Full Text] [Related]
12. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. Olivier M; Hussain SP; Caron de Fromentel C; Hainaut P; Harris CC IARC Sci Publ; 2004; (157):247-70. PubMed ID: 15055300 [TBL] [Abstract][Full Text] [Related]
13. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers. Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742 [TBL] [Abstract][Full Text] [Related]
14. [Analysis of p53 mutational spectra of esophageal squamous cell carcinomas from Linzhou, comparison with esophageal and other cancers from other areas]. Wang LD; Liu B; Zheng S Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Mar; 24(3):202-5. PubMed ID: 12816712 [TBL] [Abstract][Full Text] [Related]
15. The difference in p53 mutations between cancers of the upper and lower gastrointestinal tract. Oki E; Zhao Y; Yoshida R; Egashira A; Ohgaki K; Morita M; Kakeji Y; Maehara Y Digestion; 2009; 79 Suppl 1():33-9. PubMed ID: 19153488 [TBL] [Abstract][Full Text] [Related]
16. Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Tornaletti S; Pfeifer GP Oncogene; 1995 Apr; 10(8):1493-9. PubMed ID: 7731703 [TBL] [Abstract][Full Text] [Related]